Royal Biologics commenced commercial launch of BIO-REIGN 3D, reportedly the first natural hyper-crosslinked carbohydrate polymer bone graft substitute (BGS). Royal Biologics announces the launch in conjunction with their licensing agreement of Molecular Matrix’s patented underlying their Osteo-P BGS technology.
BIO-REIGN 3D provides an ideal microenvironment for cell proliferation and vascularization, leading to regeneration of healthy bone. BIO-REIGN 3D was designed to form a robust, highly porous bone graft substitute. The product is radiolucent upon implantation and becomes radiopaque as the bony healing occurs, which enables visualization of real-time healing.
Bio-Reign 3D provides a physical interconnected and highly porous matrix that supports osteogenic cellular infiltration leading to new bone growth. It has excellent compressibility, tensile strength and handling characteristics to provide superior moldability and malleability of the graft. BIO-REIGN 3D BGS can additionally be sutured in place to prevent graft migration.
“This is Royal Biologics’ first iteration of this new patented technology in orthopedics. We plan to continue to develop this patented technology closely with Molecular Matrix in multiple forms for tissue regeneration in orthopedics,” said Salvatore Leo, Chief Executive Officer at Royal Biologics.
Royal Biologics commenced commercial launch of BIO-REIGN 3D, reportedly the first natural hyper-crosslinked carbohydrate polymer bone graft substitute (BGS). Royal Biologics announces the launch in conjunction with their licensing agreement of Molecular Matrix’s patented underlying their Osteo-P BGS technology.
BIO-REIGN 3D provides an ideal...
Royal Biologics commenced commercial launch of BIO-REIGN 3D, reportedly the first natural hyper-crosslinked carbohydrate polymer bone graft substitute (BGS). Royal Biologics announces the launch in conjunction with their licensing agreement of Molecular Matrix’s patented underlying their Osteo-P BGS technology.
BIO-REIGN 3D provides an ideal microenvironment for cell proliferation and vascularization, leading to regeneration of healthy bone. BIO-REIGN 3D was designed to form a robust, highly porous bone graft substitute. The product is radiolucent upon implantation and becomes radiopaque as the bony healing occurs, which enables visualization of real-time healing.
Bio-Reign 3D provides a physical interconnected and highly porous matrix that supports osteogenic cellular infiltration leading to new bone growth. It has excellent compressibility, tensile strength and handling characteristics to provide superior moldability and malleability of the graft. BIO-REIGN 3D BGS can additionally be sutured in place to prevent graft migration.
“This is Royal Biologics’ first iteration of this new patented technology in orthopedics. We plan to continue to develop this patented technology closely with Molecular Matrix in multiple forms for tissue regeneration in orthopedics,” said Salvatore Leo, Chief Executive Officer at Royal Biologics.
Copy to clipboard 
